There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on SELLAS Life Sciences Group Inc (NASDAQ:SLS) and Dexcom (NASDAQ:DXCM) with bullish sentiments.
SELLAS Life Sciences Group Inc (SLS)
Maxim Group analyst Jason McCarthy maintained a Buy rating on SELLAS Life Sciences Group Inc today and set a price target of $5. The company’s shares closed yesterday at $1.08, close to its 52-week low of $1.01.
McCarthy noted:
“Sellas reported 2Q18 with a net loss of ($8.5M), of which $6.5M was operating expenses. Sellas ended the period with $1.35M in cash, excluding the $21.6M (net) raised with an equity financing in July. We estimate the company currently has ~$19M in cash on the balance sheet, runway into 1H19.”
According to TipRanks.com, McCarthy is a 5-star analyst with an average return of 12.0% and a 44.3% success rate. McCarthy covers the Healthcare sector, focusing on stocks such as ContraVir Pharmaceuticals Inc, Sonoma Pharmaceuticals Inc, and Actinium Pharmaceuticals.
Currently, the analyst consensus on SELLAS Life Sciences Group Inc is a Moderate Buy with an average price target of $4.50, a 316.7% upside from current levels. In a report issued on July 31, H.C. Wainwright also maintained a Buy rating on the stock with a $4 price target.
.
See today’s analyst top recommended stocks >>
Dexcom (DXCM)
Merrill Lynch analyst Travis Steed maintained a Buy rating on Dexcom today and set a price target of $145. The company’s shares closed yesterday at $127.43, close to its 52-week high of $127.65.
Steed has an average return of 24.5% when recommending Dexcom.
According to TipRanks.com, Steed is ranked #578 out of 4857 analysts.
Dexcom has an analyst consensus of Strong Buy, with a price target consensus of $126.55, implying a -0.7% downside from current levels. In a report issued on August 1, Piper Jaffray also maintained a Buy rating on the stock with a $150 price target.
.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
